CONCENTRIC ANALGESICS

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Preliminary Study of CA-008 (Vocacapsaicin) in Patients Undergoing Ventral Hernia Repair

Phase 1

Completed

Conditions: Postsurgical Pain

Interventions: Drug: Placebo
Drug: CA-008 (vocacapsaicin)

First Posted Date: 2021-03-01

Last Posted Date: 2022-09-14

Lead Sponsor: Concentric Analgesics

Target Recruit Count: 34

Registration Number: NCT04774328

Locations: 🇺🇸
First Surgical Hospital, Houston, Texas, United States

Study Evaluating the Safety, Efficacy and Pharmacokinetics of CA-008 (Vocacapsaicin)

Phase 1

Completed

Conditions: Postsurgical Pain

Interventions: Drug: CA-008
Drug: Placebo

First Posted Date: 2019-12-18

Last Posted Date: 2024-05-08

Lead Sponsor: Concentric Analgesics

Target Recruit Count: 193

Registration Number: NCT04203537

Locations: 🇺🇸
Lotus Clinical Reserach, LLC, Pasadena, California, United States
🇺🇸
Plano Surgical Hospital, Plano, Texas, United States
🇺🇸
Legent Orthopedic Hospital, Carrollton, Texas, United States

and more 1 locations

Open-Label CA-008 (Vocacapsaicin) in Bunionectomy

Phase 2

Completed

Conditions: Pain

Interventions: Drug: CA-008
Drug: Ketorolac
Drug: Acetaminophen IV
Drug: Fentanyl
Drug: Bupivacaine Hydrochloride
Drug: Lidocaine HCl
Drug: Exparel
Drug: Acetaminophen Oral
Drug: Celecoxib
Drug: Lidocaine Hydrochloride

First Posted Date: 2019-03-21

Last Posted Date: 2021-10-27

Lead Sponsor: Concentric Analgesics

Target Recruit Count: 36

Registration Number: NCT03885596

Locations: 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States

Study in Subjects Undergoing Complete Abdominoplasty

Phase 2

Completed

Conditions: Postsurgical Pain

Interventions: Drug: CA-008 5 mg
Drug: Placebo
Drug: Bupivacaine Hydrochloride
Drug: Hydromorphone
Drug: Fentanyl
Drug: Acetaminophen
Drug: Oxycodone
Drug: CA-008 10 mg
Drug: CA-008 15 mg

First Posted Date: 2018-12-28

Last Posted Date: 2024-03-19

Lead Sponsor: Concentric Analgesics

Target Recruit Count: 54

Registration Number: NCT03789318

Locations: 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States

Study of CA-008 (Vocacapsaicin) in Total Knee Arthroplasty

Phase 2

Completed

Conditions: Postsurgical Pain

Interventions: Drug: CA-008
Drug: Placebo

First Posted Date: 2018-11-06

Last Posted Date: 2022-02-15

Lead Sponsor: Concentric Analgesics

Target Recruit Count: 55

Registration Number: NCT03731364

Locations: 🇺🇸
HD Research, Houston, Texas, United States

Study of CA-008 (Vocacapsaicin) in Bunionectomy Patients

Phase 2

Completed

Conditions: Post-surgical Pain

Interventions: Drug: CA-008
Drug: Placebo
Drug: Ketorolac
Drug: Acetaminophen
Drug: Oxycodone
Drug: Bupivacaine Hydrochloride

First Posted Date: 2018-07-26

Last Posted Date: 2021-08-11

Lead Sponsor: Concentric Analgesics

Target Recruit Count: 147

Registration Number: NCT03599089

Locations: 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
🇺🇸
Chesapeake Research Group, Pasadena, Maryland, United States
🇺🇸
HD Research Corp, Houston, Texas, United States

A Phase 1 Study of Intraoperative Administration of CA-008 for the Correction of Hallux Valgus Deformity

Phase 1

Completed

Conditions: Hallux Valgus Deformity

Interventions: Drug: CA-008
Drug: Placebo

First Posted Date: 2017-10-12

Last Posted Date: 2021-06-30

Lead Sponsor: Concentric Analgesics

Target Recruit Count: 40

Registration Number: NCT03307837

Locations: 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy